Healthcare

DXB, AT1, JTL: How did these healthcare penny stocks fare in March q...

Highlights Penny stocks are generally priced below one dollar DXB has received the Orphan Drug Designation for DMX 200 in both the US and Europe...

Life360 Inc’s (ASX: 360) subscription revenue rises 63% in FY22

Highlights With a 43% yoy (year-on-year) increase in paying circles and a 63% yoy (year-on-year) growth in subscription revenue, Life360’s ma...

Actinogen gets upbeat results from Xanamem trial for Alzheimer’s tre...

Highlights Actinogen Medical receives encouraging results for XanaMIA Part A trial for its lead compound Xanamem The results confirm the potential...

Jatcorp (ASX: JAT) reports strong revenue growth in March quarter

Highlights The ease in pandemic restrictions has put Jatcorp in an excellent position to reap the benefits of investments made since 2020 The co...

PolyNovo (ASX:PNV) charged up on record revenue in March quarter

Highlights PolyNovo has delivered a return of AU$12.26 million in the March quarter. Proceeds for the Lorimer Street property sale is expected in...

ACW, IHL & CGS: ASX healthcare penny stocks with over 150% returns i...

Highlights Penny stocks have strong potential to yield lucrative rewards. They are extremely volatile; thus, investors should do proper due dilige...

MX1, MDR, and OSX: Medical technology stocks from ASX

Highlights Products, services, and solutions used in the medical field are known as medical technologies Pregnancy tests and X-rays are one of the...

BGH intends to make new Virtus (ASX:VRT) bid at AU$8 cash per share

Highlights BGH Capital is considering making an off-market takeover offer to acquire all fully paid ordinary shares (Shares) in Virtus Health Limit...

All you need to know about the S&P/ASX 200 Health Care

Highlights Indices are benchmark and a standard reference point for the entire stock market Comparison with an index gives an easy assessment of a...

What about the Cyber Security bill is ailing private hospitals?

Highlights According to the new Cyber Security Bill proposed in Australia, private hospitals with Intensive Care Units must comply with cyber secur...

Anatara Life Sciences (ASX: ANR) swiftly progresses its clinical tri...

Highlights Anatara Lifesciences is advancing well in its clinical trials in psychological functioning and irritable bowel syndrome, diarrhoea subty...

PCK, LBT, OPL – Three AI stocks from ASX healthcare

Highlights Integrating AI into medical sector can enhance different processes like medical screenings, diagnosis, and patient data Cardiology, neu...

How have REG, CSL share prices fared after budget’s healthcare boost...

Highlights ASX-listed healthcare stocks have gained after the budget presentation. The stocks received a significant boost from extra spen...

Polynovo (ASX:PNV) shows uptrend after shedding 58% in a year

Highlights Polynovo shares have been gaining attention despite no new announcement. The stock that dropped over 58% in the last 12 months, has bee...

Living Cell (ASX:LCT) surges over 14% on clinical trial for Parkinso...

Highlights LCT has inked a deal with University of Technology to utilise university facilities in Sydney. NTCELL capsules will be manufactured in...

Telix (ASX:TLX) shares jump on receiving an FDA approval

Highlights Telix has been granted an FDA approval for Orphan Drug Designation for bone marrow conditioning treatment. Telix is a biopharmaceutical...

CapVest Partners gets approval from FIRB to takeover Virtus Health (...

Highlights CapVest Partners has received confirmation from FIRB to buy Virtus Health. This follows an announcement by the company on 14 March 2022...

Incannex (ASX: IHL) signs term sheet to snap up APIRx Pharmaceutical...

A clinical-stage pharmaceutical company, Incannex Healthcare Limited (ASX: IHL) (Nasdaq: IXHL) has executed a term sheet with binding commercial terms...

ASX food and beverage stocks with highest 52-week return - GNC, LRK...

The term consumer staples represents a range of essential products used by customers. This group includes things like foods and beverages, household g...

From Metcash to Ansell: 5 ASX healthcare mid-cap shares in focus

On the Australian Securities Exchange (ASX), mid-cap stocks are the stocks whose market capitalisation ranges from AU$2 billion to AU$10 billion, i.e....